MultiHance® 9 Image Library 9 Seidl et al. 58F with melanoma and brain metastases

MultiHance® (gadobenate dimeglumine) injection, 529 mg/mL vs. Gadavist® (gadobutrol)1

The MERIT Study
Seidl et al.
58-year-old woman with melanoma and brain metastases

These are representative images from reference studies; individual results may vary.
Reference: 1. Seidl Z, Vymazal J, Mechi M, et al. Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study). AJNR Am J Neuroradiol. 2012 Jun-Jul;33(6):1050-1058.

View Full Image Library

More cases that may interest you

Seidl et al. 70M Metastatic Lung Carcinoma
Seidl et al. 70M Metastatic Lung Carcinoma
Seidl et al. 58F Metastatic Melanoma
Seidl et al. 58F Metastatic Melanoma
Rowley et al. 55F Glioblastoma with Recurrent Disease
Rowley et al. 55F Glioblastoma with Recurrent Disease
Maravilla et al. 51F Metastatic Lung Cancer
Maravilla et al. 51F Metastatic Lung Cancer